Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

371 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Altered axonal excitability properties and nerve edema in POEMS syndrome.
Mitsuma S, Misawa S, Shibuya K, Isose S, Sekiguchi Y, Iwai Y, Beppu M, Watanabe K, Amino H, Kuwabara S. Mitsuma S, et al. Among authors: beppu m. Clin Neurophysiol. 2015 Oct;126(10):2014-8. doi: 10.1016/j.clinph.2015.01.018. Epub 2015 Feb 11. Clin Neurophysiol. 2015. PMID: 25735476
Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome.
Sekiguchi Y, Misawa S, Shibuya K, Nasu S, Mitsuma S, Iwai Y, Beppu M, Sawai S, Ito S, Hirano S, Nakaseko C, Kuwabara S. Sekiguchi Y, et al. Among authors: beppu m. J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1346-8. doi: 10.1136/jnnp-2012-304874. Epub 2013 Mar 5. J Neurol Neurosurg Psychiatry. 2013. PMID: 23463868
Duration of the distal compound muscle action potential for diagnosis of chronic inflammatory demyelinating polyneuropathy: effects of low-cut filters.
Isose S, Misawa S, Sonoo M, Shimuzu T, Oishi C, Shibuya K, Nasu S, Sekiguchi Y, Mitsuma S, Beppu M, Omori S, Komori T, Kokubun N, Inaba A, Hirashima F, Kuwabara S; Tokyo Metropolitan Neuromuscular Electrodiagnosis Study Group. Isose S, et al. Among authors: beppu m. J Clin Neurophysiol. 2014 Oct;31(5):441-3. doi: 10.1097/WNP.0000000000000045. J Clin Neurophysiol. 2014. PMID: 25271683
A single blind randomized controlled clinical trial of mexiletine in amyotrophic lateral sclerosis: Efficacy and safety of sodium channel blocker phase II trial.
Shibuya K, Misawa S, Kimura H, Noto Y, Sato Y, Sekiguchi Y, Iwai Y, Mitsuma S, Beppu M, Watanabe K, Fujimaki Y, Tsuji Y, Shimizu T, Mizuno T, Nakagawa M, Sawaguchi K, Hanaoka H, Kuwabara S. Shibuya K, et al. Among authors: beppu m. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(5-6):353-8. doi: 10.3109/21678421.2015.1038277. Epub 2015 May 11. Amyotroph Lateral Scler Frontotemporal Degener. 2015. PMID: 25960085 Clinical Trial.
371 results